The estimated Net Worth of Bradford K. Amman is at least $275 millier dollars as of 25 May 2021. Mr Amman owns over 1,000 units of Vivos Therapeutics stock worth over $6,080 and over the last 17 years he sold VVOS stock worth over $0. In addition, he makes $268,938 as CFO et Treasurer & Sec. at Vivos Therapeutics.
Sign up
Mr Amman VVOS stock SEC Form 4 insiders trading
Mr has made over 3 trades of the Vivos Therapeutics stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of VVOS stock worth $5,290 on 25 May 2021.
The largest trade he's ever made was buying 50,000 units of Vivos Therapeutics stock on 27 March 2009 worth over $10,000. On average, Mr trades about 5,778 units every 494 days since 2008. As of 25 May 2021 he still owns at least 2,000 units of Vivos Therapeutics stock.
You can see the complete history of Mr Amman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Bradford K. Amman biography
Bradford K. Amman is the CFO, Treasurer & Sec. at Vivos Therapeutics.
What is the salary of Mr Amman?
As the CFO et Treasurer & Sec. of Vivos Therapeutics, the total compensation of Mr Amman at Vivos Therapeutics is $268,938. There are 2 executives at Vivos Therapeutics getting paid more, with R. Kirk Huntsman having the highest compensation of $455,336.
How old is Mr Amman?
Mr Amman is 59, he's been the CFO et Treasurer & Sec. of Vivos Therapeutics since . There are 2 older and 2 younger executives at Vivos Therapeutics. The oldest executive at Vivos Therapeutics, Inc. is R. Kirk Huntsman, 63, who is the Co-Founder, Chairman & CEO.
What's Mr Amman's mailing address?
Bradford's mailing address filed with the SEC is 7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120.
Insiders trading at Vivos Therapeutics
Over the last 4 years, insiders at Vivos Therapeutics have traded over $0 worth of Vivos Therapeutics stock and bought 88,521 units worth $136,211 . The most active insiders traders include Anja B Krammer, Ronald Kirk Huntsman et Bradford K. Amman. On average, Vivos Therapeutics executives and independent directors trade stock every 77 days with the average trade being worth of $22,426. The most recent stock trade was executed by Ronald Kirk Huntsman on 20 June 2023, trading 14,000 units of VVOS stock currently worth $7,420.
What does Vivos Therapeutics do?
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
What does Vivos Therapeutics's logo look like?
Complete history of Mr Amman stock trades at Lifevantage et Vivos Therapeutics
Vivos Therapeutics executives and stock owners
Vivos Therapeutics executives and other stock owners filed with the SEC include:
-
R. Kirk Huntsman,
Co-Founder, Chairman & CEO -
Dr. Gurdev Dave Singh D.M.D., Ph.D.,
Founder, Chief Medical Officer & Director -
Bradford K. Amman,
CFO, Treasurer & Sec. -
Ruth Hembree,
Sr. VP -
Nicholas M. DeGennaro,
Sr. VP of the Medical Integration Division -
David Bryan Ferre,
Sr. VP of Marketing -
Cathryn H. Bonar,
Chief Compliance Officer and Sr. VP of Compliance & Medical Billing -
Edward A. Loew,
Chief Strategy Officer, Sr. VP of Strategy & Investor Relations Officer -
Susan McCullough,
Co-Founder & Sr. VP of Operations -
RaeAnn Byrnes,
Co-Founder and Sr. VP of People, Training & Devel. -
Todd Huntsman,
Co-Founder & Sr. VP of Manufacturing -
Bradford K. Amman,
Chief Financial Officer -
Leonard J Sokolow,
Director -
Anja B Krammer,
Director -
Ralph Elias Green,
Director -
Mark F. Lindsay,
Director -
Gurdev Dave Singh,
Chief Medical Officer -
Matthew Thompson,
Director -
Ronald Kirk Huntsman,
Chief Executive Officer